These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4921295)

  • 1. Levodopa (Larodopa). For the relief of symptoms associated with Parkinson's disease and syndrome.
    Clin Pharmacol Ther; 1970; 11(6):921-4. PubMed ID: 4921295
    [No Abstract]   [Full Text] [Related]  

  • 2. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A; Bartholini G; Gey KF; Jenni A
    Schweiz Med Wochenschr; 1970 May; 100(19):797-804. PubMed ID: 4924275
    [No Abstract]   [Full Text] [Related]  

  • 3. Symposium on levodopa in Parkinson's disease. Clinical and pharmacological aspects. Where do we go from here?
    Clin Pharmacol Ther; 1971; 12(2):408-16. PubMed ID: 5577487
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of Levodopa for Parkinsonism. Levodopa (Dopar, Larodopa).
    JAMA; 1971 Mar; 215(12):1969-72. PubMed ID: 4396120
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
    McDowell F; Lee JE; Swift T; Sweet RD; Ogsbury JS; Kessler JT
    Ann Intern Med; 1970 Jan; 72(1):29-35. PubMed ID: 5410397
    [No Abstract]   [Full Text] [Related]  

  • 6. Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.
    Brogden RN; Speight TM; Avery GS
    Drugs; 1971; 2(4):262-400. PubMed ID: 4340597
    [No Abstract]   [Full Text] [Related]  

  • 7. Levodopa.
    Lancet; 1971 Sep; 2(7723):533. PubMed ID: 4105672
    [No Abstract]   [Full Text] [Related]  

  • 8. Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.
    Langrall HM; Joseph C
    Clin Pharmacol Ther; 1971; 12(2):323-31. PubMed ID: 4930865
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Parkinson's disease with levodopa and Ro 4-4602.
    Barbeau A; Gillo-Joffroy L; Mars H
    Clin Pharmacol Ther; 1971; 12(2):353-9. PubMed ID: 4930866
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 11. Parkinsonism, levodopa, and anesthesia.
    Ngai SH
    Anesthesiology; 1972 Sep; 37(3):344-51. PubMed ID: 4559395
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind study of the effects of levodopa in Parkinson's disease.
    Nakano KK; Tyler HR
    Neurology; 1971 Oct; 21(10):1069-74. PubMed ID: 4939556
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of Parkinson's disease with Levodopa.
    Calhoun CL
    J Natl Med Assoc; 1972 Nov; 64(6):516-7 passim. PubMed ID: 4639943
    [No Abstract]   [Full Text] [Related]  

  • 14. The clinical use of levodopa in the treatment of Parkinson's disease.
    McDowell FH; Markham CH; Lee JE; Treciokas LJ; Ansel RD
    Contemp Neurol Ser; 1971; 8():175-201. PubMed ID: 4950056
    [No Abstract]   [Full Text] [Related]  

  • 15. Levodopa in Parkinsonism: potentiation of central effects with a peripheral inhibitor.
    Papavasiliou PS; Cotzias GC; Düby SE; Steck AJ; Fehling C; Bell MA
    N Engl J Med; 1972 Jan; 286(1):8-14. PubMed ID: 4550085
    [No Abstract]   [Full Text] [Related]  

  • 16. Levodopa and relief of Parkinsonian symptoms.
    Schmidt RP; Greer M
    Arq Neuropsiquiatr; 1971 Mar; 29(1):21-5. PubMed ID: 5158712
    [No Abstract]   [Full Text] [Related]  

  • 17. Double-blind, placebo-controlled study of levodopa therapy in Parkinson's disease.
    Muenter MD
    Neurology; 1970 Dec; 20(12):6-13. PubMed ID: 4924343
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of L-dopa in Parkinson's disease.
    Godwin-Austen RB; Tomlinson EB; Frears CC; Kok HW
    Lancet; 1969 Jul; 2(7613):165-8. PubMed ID: 4183130
    [No Abstract]   [Full Text] [Related]  

  • 19. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease.
    Andrews CJ; Somerville B
    Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term treatment of Parkinson's disease with levodopa.
    Martin WE; Loewenson RB; Bilek MK; Resch JA; Baker AB
    J Chronic Dis; 1974 Feb; 27(1):77-93. PubMed ID: 4815073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.